SCH 900271
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCH 900271, covering 2016-04-12 to 2016-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) [Phase 2]